Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide, particularly in Asian populations, and responds poorly to conventional therapy. Subclassification of ESCCs by molecular analysis is a powerful strategy in extending conventional clinicopathologic classification, i...

Full description

Bibliographic Details
Main Authors: Fengling Wang, Zhongyi Yan, Jiajia Lv, Junfang Xin, Yifang Dang, Xiaoxiao Sun, Yang An, Yijun Qi, Qiying Jiang, Wan Zhu, Yongqiang Li, Ao Li, Xiangqian Guo
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558619300168
id doaj-47b243a18a56450a909b4fc47c6b32f1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Fengling Wang
Zhongyi Yan
Jiajia Lv
Junfang Xin
Yifang Dang
Xiaoxiao Sun
Yang An
Yijun Qi
Qiying Jiang
Wan Zhu
Yongqiang Li
Ao Li
Xiangqian Guo
spellingShingle Fengling Wang
Zhongyi Yan
Jiajia Lv
Junfang Xin
Yifang Dang
Xiaoxiao Sun
Yang An
Yijun Qi
Qiying Jiang
Wan Zhu
Yongqiang Li
Ao Li
Xiangqian Guo
Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
Neoplasia: An International Journal for Oncology Research
author_facet Fengling Wang
Zhongyi Yan
Jiajia Lv
Junfang Xin
Yifang Dang
Xiaoxiao Sun
Yang An
Yijun Qi
Qiying Jiang
Wan Zhu
Yongqiang Li
Ao Li
Xiangqian Guo
author_sort Fengling Wang
title Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
title_short Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
title_full Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
title_fullStr Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
title_full_unstemmed Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian Populations
title_sort gene expression profiling reveals distinct molecular subtypes of esophageal squamous cell carcinoma in asian populations
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
publishDate 2019-06-01
description Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide, particularly in Asian populations, and responds poorly to conventional therapy. Subclassification of ESCCs by molecular analysis is a powerful strategy in extending conventional clinicopathologic classification, improving prognosis and therapy. Here we identified two ESCC molecular subtypes in Chinese population using gene expression profiling data and further validated the molecular subtypes in two other independent Asian populations (Japanese and Vietnamese). Subtype I ESCCs were enriched in pathways including immune response, while genes overexpressed in subtype II ESCCs were mainly involved in ectoderm development, glycolysis process, and cell proliferation. Specifically, we identified potential ESCC subtype-specific diagnostic markers (FOXA1 and EYA2 for subtype I, LAMC2 and KRT14 for subtype II) and further validated them in a fourth Asian cohort. In addition, we propose a few subtype-specific therapeutic targets for ESCC, which may guide future ESCC clinical treatment when further validated.
url http://www.sciencedirect.com/science/article/pii/S1476558619300168
work_keys_str_mv AT fenglingwang geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT zhongyiyan geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT jiajialv geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT junfangxin geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT yifangdang geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT xiaoxiaosun geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT yangan geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT yijunqi geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT qiyingjiang geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT wanzhu geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT yongqiangli geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT aoli geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
AT xiangqianguo geneexpressionprofilingrevealsdistinctmolecularsubtypesofesophagealsquamouscellcarcinomainasianpopulations
_version_ 1725251352256315392
spelling doaj-47b243a18a56450a909b4fc47c6b32f12020-11-25T00:49:45ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862019-06-01216571581Gene Expression Profiling Reveals Distinct Molecular Subtypes of Esophageal Squamous Cell Carcinoma in Asian PopulationsFengling Wang0Zhongyi Yan1Jiajia Lv2Junfang Xin3Yifang Dang4Xiaoxiao Sun5Yang An6Yijun Qi7Qiying Jiang8Wan Zhu9Yongqiang Li10Ao Li11Xiangqian Guo12Department of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaHenan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang 471003, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaDepartment of Anesthesia, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USADepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, ChinaSchool of Information Science and Technology, Centers for Biomedical Engineering, University of Science and Technology of China, Hefei 230027, ChinaDepartment of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China; Address all correspondence to: Prof. Xiangqian Guo, Department of Preventive Medicine, Institute of Biomedical Informatics, Joint National Laboratory for Antibody Drug Engineering, Cell Signal Transduction Laboratory, School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide, particularly in Asian populations, and responds poorly to conventional therapy. Subclassification of ESCCs by molecular analysis is a powerful strategy in extending conventional clinicopathologic classification, improving prognosis and therapy. Here we identified two ESCC molecular subtypes in Chinese population using gene expression profiling data and further validated the molecular subtypes in two other independent Asian populations (Japanese and Vietnamese). Subtype I ESCCs were enriched in pathways including immune response, while genes overexpressed in subtype II ESCCs were mainly involved in ectoderm development, glycolysis process, and cell proliferation. Specifically, we identified potential ESCC subtype-specific diagnostic markers (FOXA1 and EYA2 for subtype I, LAMC2 and KRT14 for subtype II) and further validated them in a fourth Asian cohort. In addition, we propose a few subtype-specific therapeutic targets for ESCC, which may guide future ESCC clinical treatment when further validated.http://www.sciencedirect.com/science/article/pii/S1476558619300168